Business Context and Reporting Period
This Form 8-K is a current report filed by Healthcare Trust, Inc. (not National Healthcare Properties, Inc.) on October 3, 2022. The filing addresses Item 8.01 (Other Events) regarding the declaration of a quarterly common stock dividend.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial data disclosed relates to the dividend policy:
- Dividend Type: Quarterly stock dividend.
- Dividend Rate: 0.014167 shares of common stock per outstanding share.
- Annualized Value: $0.85 per share per annum ($0.2125 per quarter).
- Valuation Basis: Based on an estimated per share net asset value (NAV) of $15.00.
- Payment Date: October 17, 2022.
- Record Date: October 13, 2022.
Material Changes
The filing does not report material changes to revenue, operations, or financial position compared to prior periods. It solely announces the routine quarterly dividend declaration consistent with the company's established policy of paying dividends in shares of common stock valued at the estimated NAV.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statement disclaimers and identifies specific risks that could cause actual results to differ materially from expectations:
- Inflation: Potential impact on the Company's costs and expenses.
- Pandemic: Adverse effects of the ongoing global COVID-19 pandemic and containment measures.
- Geopolitical Instability: Risks related to the military conflict between Russia and Ukraine, including sanctions and impacts on the global economy and financial markets.
- Acquisitions: Future acquisitions are subject to market conditions and capital availability and may not be completed on favorable terms.
Investor Verification Checklist
- Verify the correct registrant name is Healthcare Trust, Inc. (HTIA/HTIBP), not National Healthcare Properties, Inc.
- Confirm the dividend payment date (October 17, 2022) and record date (October 13, 2022) for shareholder eligibility.
- Review the April 1, 2022 Form 8-K referenced in the text for the full methodology behind the $15.00 estimated NAV.
- Assess the impact of the cited geopolitical and inflation risks on the company's underlying healthcare real estate portfolio.